Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

Contacts

Investor Relations

Lytham Partners, LLC
Joe Dorame
Managing Partner
T: (602) 889-9700

Transfer Agent

VStock Transfer, LLC

Auditor

Grant Thornton LLP

Legal Counsel

Schiff Hardin LLP
Cavas Pavri